test 3 2008 test

test 3 2008 test - 1 Test #3 IPPH 362 10/30/08 Name_ Seat_...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
1 Test #3 IPPH 362 10/30/08 Name______________________ Seat____________________ I. Short Answers. Each answer is worth 2 points except as noted in question 1. No partial credit. 1. Circle the drugs that have a narrow therapeutic window. (1 point each) carbamazepine digoxin neomycin nitrofurantoin nitroglycerin oxytetracycline phenobarbital phenytoin theophylline warfarin ______ 2. The shelf life is usually the time during which at least ______% of the labeled amount of drug is present. 3. Name a drug that produces a toxic degradation product. ____________________________________________________________ 4. The statistical test used to evaluate the significance of apparent differences between blood level or urinary excretion curves is known as ____________________________________________________________ 5. It is desirable to input the drug directly to the site of action. Give two examples where this is currently being done. 1. 2.
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
2 6. Briefly explain why drugs administered orally may undergo the hepatic first pass effect. _____________________________________________________________________ _____________________________________________________________________ 7. The lungs act to enhance safety following intravenous administration. Name two
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 5

test 3 2008 test - 1 Test #3 IPPH 362 10/30/08 Name_ Seat_...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online